{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:35:18Z","timestamp":1794645318873,"version":"4.9.1"},"reference-count":50,"publisher":"BMJ","issue":"10","funder":[{"DOI":"10.13039\/501100000659","name":"Research Trainees Coordinating Centre","doi-asserted-by":"publisher","award":["DRF-2013-06-076"],"award-info":[{"award-number":["DRF-2013-06-076"]}],"id":[{"id":"10.13039\/501100000659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001881","name":"Service Delivery and Organisation programme","doi-asserted-by":"publisher","award":["IS-BRC-1215-20017"],"award-info":[{"award-number":["IS-BRC-1215-20017"]}],"id":[{"id":"10.13039\/501100001881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001881","name":"Service Delivery and Organisation programme","doi-asserted-by":"publisher","award":["NF-SI-0512-10082"],"award-info":[{"award-number":["NF-SI-0512-10082"]}],"id":[{"id":"10.13039\/501100001881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,7,25]]},"published-print":{"date-parts":[[2019,10]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Care of patients with motor neuron disease (MND) in a specialist, multidisciplinary clinic is associated with improved survival, but access is not universal. We wanted to pilot and establish the feasibility of a definitive trial of a novel telehealth system (Telehealth in Motor neuron disease, TiM) in patients with MND.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>An 18-month, single-centre, mixed-methods, randomised, controlled pilot and feasibility study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Intervention<\/jats:title>\n                    <jats:p>TiM telehealth plus usual care versus usual care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Setting<\/jats:title>\n                    <jats:p>A specialist MND care centre in the UK.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>Patients with MND and their primary informal carers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Primary and secondary outcome measures<\/jats:title>\n                    <jats:p>Recruitment, retention and data collection rates, clinical outcomes including participant quality of life and anxiety and depression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Recruitment achieved the target of 40 patients and 37 carers. Participant characteristics reflected those attending the specialist clinic and included those with severe disability and those with limited experience of technology. Retention and data collection was good. Eighty per cent of patients and 82% of carer participants reported outcome measures were completed at 6 months. Using a longitudinal analysis with repeated measures of quality of life (QoL), a sample size of 131 per arm is recommended in a definitive trial. The methods and intervention were acceptable to participants who were highly motivated to participate to research. The low burden of participation and accessibility of the intervention meant barriers to participation were minimal. However, the study highlighted difficulties assessing the associated costs of the intervention, the challenge of recruitment in such a rare disease and the difficulties of producing rigorous evidence of impact in such a complex intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>A definitive trial of TiM is feasible but challenging. The complexity of the intervention and heterogeneity of the patient population means that a randomised controlled trial may not be the best way to evaluate the further development and implementation of the TiM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"ISRCTN26675465\">ISRCTN26675465<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2018-028525","type":"journal-article","created":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T15:35:18Z","timestamp":1571758518000},"page":"e028525","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":42,"title":["Using telehealth in motor neuron disease to increase access to specialist multidisciplinary care: a UK-based pilot and feasibility study"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8497-2338","authenticated-orcid":false,"given":"Esther V","family":"Hobson","sequence":"first","affiliation":[{"name":"Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK"},{"name":"Academic Department of Neurology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4253-2721","authenticated-orcid":false,"given":"Wendy O","family":"Baird","sequence":"additional","affiliation":[{"name":"School of Health and Related Research, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3783-9761","authenticated-orcid":false,"given":"Mike","family":"Bradburn","sequence":"additional","affiliation":[{"name":"Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2995-5447","authenticated-orcid":false,"given":"Cindy","family":"Cooper","sequence":"additional","affiliation":[{"name":"Clinical Trials Research Unit, School of Health and Related Research, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2795-8983","authenticated-orcid":false,"given":"Susan","family":"Mawson","sequence":"additional","affiliation":[{"name":"School of Health and Related Research, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Quinn","sequence":"additional","affiliation":[{"name":"Sheffield Motor Neurone Disease Association Research Advisory Group, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8925-2567","authenticated-orcid":false,"given":"Pamela J","family":"Shaw","sequence":"additional","affiliation":[{"name":"Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK"},{"name":"Academic Department of Neurology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Walsh","sequence":"additional","affiliation":[{"name":"Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK"},{"name":"Academic Department of Neurology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1269-9053","authenticated-orcid":false,"given":"Christopher J","family":"McDermott","sequence":"additional","affiliation":[{"name":"Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK"},{"name":"Academic Department of Neurology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,10,22]]},"reference":[{"key":"2025120618575284000_9.10.e028525.1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39493.511759.BE"},{"key":"2025120618575284000_9.10.e028525.2","doi-asserted-by":"crossref","unstructured":"Miller RG , Mitchell JD , Lyon M , Moore DH , et al . Riluzole for amyotrophic lateral sclerosis (ALS)\/motor neuron disease (MND). Cochrane Database Syst Rev 2002;(2):CD001447.doi:10.1002\/14651858.CD001447","DOI":"10.1002\/14651858.CD001447"},{"key":"2025120618575284000_9.10.e028525.3","doi-asserted-by":"crossref","unstructured":"Radunovic A , Annane D , Rafiq MK , Jewitt K , et al . Mechanical ventilation for amyotrophic lateral sclerosis\/motor neuron disease. Cochrane Database Syst Rev 2013;(3):CD004427.doi:10.1002\/14651858.CD004427.pub3","DOI":"10.1002\/14651858.CD004427.pub3"},{"key":"2025120618575284000_9.10.e028525.4","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S1474-4422(17)30163-1","article-title":"Edaravone: a new treatment for ALS on the horizon?","volume":"16","author":"Hardiman","year":"2017","journal-title":"Lancet Neurol"},{"key":"2025120618575284000_9.10.e028525.5","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.74.9.1258"},{"key":"2025120618575284000_9.10.e028525.6","doi-asserted-by":"crossref","unstructured":"Ng L , Khan F , Cochrane Neuromuscular Group . Multidisciplinary care for adults with amyotrophic lateral sclerosis or motor neuron disease. Cochrane Database Syst Rev 2009;13.doi:10.1002\/14651858.CD007425.pub2","DOI":"10.1002\/14651858.CD007425.pub2"},{"key":"2025120618575284000_9.10.e028525.7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/17482968.2012.690419","article-title":"The natural history of motor neuron disease: assessing the impact of specialist care","volume":"14","author":"Aridegbe","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2025120618575284000_9.10.e028525.8","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309601"},{"key":"2025120618575284000_9.10.e028525.9","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/21678421.2017.1349151","article-title":"The benefit of evolving multidisciplinary care in ALS: a diagnostic cohort survival comparison","volume":"18","author":"Martin","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2025120618575284000_9.10.e028525.10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4172\/2329-6895.1000327","article-title":"Multidisciplinary care improves survival of patients with amyotrophic lateral sclerosis in the unique health system (Sus) in Brazil","volume":"05","author":"Moura","year":"2017","journal-title":"J Neurol Disord"},{"key":"2025120618575284000_9.10.e028525.11","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2016.111"},{"key":"2025120618575284000_9.10.e028525.12","unstructured":"National Institute for Clinical Excellence, UK . Motor neurone disease: assessment and management [NG42]; 2016: 1\u201347."},{"key":"2025120618575284000_9.10.e028525.13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2011.03501.x"},{"key":"2025120618575284000_9.10.e028525.14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/JMDH.S134992","article-title":"Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach","volume":"10","author":"Hogden","year":"2017","journal-title":"J Multidiscip Healthc"},{"key":"2025120618575284000_9.10.e028525.15","doi-asserted-by":"publisher","DOI":"10.1159\/000351153"},{"key":"2025120618575284000_9.10.e028525.16","doi-asserted-by":"publisher","DOI":"10.1177\/0269216311410900"},{"key":"2025120618575284000_9.10.e028525.17","doi-asserted-by":"publisher","DOI":"10.1177\/0269216311398697"},{"key":"2025120618575284000_9.10.e028525.18","doi-asserted-by":"publisher","DOI":"10.1080\/17482960601164532"},{"key":"2025120618575284000_9.10.e028525.19","doi-asserted-by":"publisher","DOI":"10.1177\/0269216313478449"},{"key":"2025120618575284000_9.10.e028525.20","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-11-103"},{"key":"2025120618575284000_9.10.e028525.21","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2524.2001.00320.x"},{"key":"2025120618575284000_9.10.e028525.22","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/21678421.2018.1440408","article-title":"The TiM system: developing a novel telehealth service to improve access to specialist care in motor neurone disease using user-centered design","volume":"19","author":"Hobson","year":"2018","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2025120618575284000_9.10.e028525.23","unstructured":"Medical Research Council . A framework for development and evaluation of RCTs for complex interventions to improve health MRC; 2000."},{"key":"2025120618575284000_9.10.e028525.24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e3874"},{"key":"2025120618575284000_9.10.e028525.25","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-10-201205150-00003"},{"key":"2025120618575284000_9.10.e028525.26","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2012.256"},{"key":"2025120618575284000_9.10.e028525.27","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318232ab9b"},{"key":"2025120618575284000_9.10.e028525.28","doi-asserted-by":"crossref","DOI":"10.1186\/1745-6215-14-353","article-title":"A process for decision-making after pilot and feasibility trials (ADEPT): development following a feasibility study of a complex intervention for pelvic organ prolapse","volume":"14","author":"Bugge","year":"2013","journal-title":"Trials"},{"key":"2025120618575284000_9.10.e028525.29","doi-asserted-by":"crossref","unstructured":"Hobson EV , Baird WO , Bradburn MJ , et al . Process evaluation and exploration of telehealth in motor neurone disease in a UK specialist centre. BMJ open 2019.","DOI":"10.1136\/bmjopen-2018-028526"},{"key":"2025120618575284000_9.10.e028525.30","doi-asserted-by":"publisher","DOI":"10.1016\/0022-510X(94)90191-0"},{"key":"2025120618575284000_9.10.e028525.31","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(99)00210-5"},{"key":"2025120618575284000_9.10.e028525.32","unstructured":"QSR . NVivo qualitative data analysis software QSR International Pty Ltd. 2014."},{"key":"2025120618575284000_9.10.e028525.33","doi-asserted-by":"publisher","DOI":"10.1191\/1478088706qp063oa"},{"key":"2025120618575284000_9.10.e028525.34","doi-asserted-by":"publisher","DOI":"10.1002\/pst.185"},{"key":"2025120618575284000_9.10.e028525.35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3109\/21678421.2014.932384","article-title":"Investigating the economic burden of ALS in Greece: a cost-of-illness approach","volume":"16","author":"Athanasakis","year":"2015","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"2025120618575284000_9.10.e028525.36","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-306865"},{"key":"2025120618575284000_9.10.e028525.37","unstructured":"Diggle PJ , Heagerty PJ , Liang K , et al . Analysis of longitudinal data. In: Oxford statistical science series. 2nd ed. Oxford University Press, 2002."},{"key":"2025120618575284000_9.10.e028525.38","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S1474-4422(15)00152-0","article-title":"Safety and efficacy of diaphragm pacing in patients with respiratory insufficiency due to amyotrophic lateral sclerosis (DiPALS): a multicentre, open-label, randomised controlled trial","volume":"14","year":"2015","journal-title":"Lancet Neurol"},{"key":"2025120618575284000_9.10.e028525.39","doi-asserted-by":"publisher","DOI":"10.1080\/17482960802195632"},{"key":"2025120618575284000_9.10.e028525.40","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2013.778571."},{"key":"2025120618575284000_9.10.e028525.41","doi-asserted-by":"crossref","unstructured":"McDonald AM , Knight RC , Campbell MK , et al . What influences recruitment to randomised controlled trials? A review of trials funded by two UK funding agencies. Trials 2006;7.doi:10.1186\/1745-6215-7-9","DOI":"10.1186\/1745-6215-7-9"},{"key":"2025120618575284000_9.10.e028525.42","unstructured":"MND Register . The MND register of England, Wales and Northern Ireland, 2016. Available: https:\/\/mndregister.ac.uk [Accessed 9 Dec 2018]."},{"key":"2025120618575284000_9.10.e028525.43","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f1035"},{"key":"2025120618575284000_9.10.e028525.44","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i154"},{"key":"2025120618575284000_9.10.e028525.45","first-page":"1878","article-title":"Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials","volume":"342","author":"Anglemyer","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"2025120618575284000_9.10.e028525.46","doi-asserted-by":"crossref","unstructured":"Kunz R , Vist G , Oxman AD , et al . Randomisation to protect against selection bias in healthcare trials. Cochrane Database Syst Rev 2007;(2):MR000012.doi:10.1002\/14651858.MR000012.pub2","DOI":"10.1002\/14651858.MR000012.pub2"},{"key":"2025120618575284000_9.10.e028525.47","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7256.255"},{"key":"2025120618575284000_9.10.e028525.48","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.299.6694.313"},{"key":"2025120618575284000_9.10.e028525.49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12872-017-0594-2","article-title":"Understanding heart failure; explaining telehealth \u2013 a hermeneutic systematic review","volume":"17","author":"Greenhalgh","year":"2017","journal-title":"BMC Cardiovasc Disord"},{"key":"2025120618575284000_9.10.e028525.50","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-015-1195-3","article-title":"Implementing solutions to improve and expand telehealth adoption: participatory action research in four community healthcare settings","volume":"15","author":"Taylor","year":"2015","journal-title":"BMC Health Serv Res"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2018-028525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T02:58:04Z","timestamp":1765076284000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2018-028525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10,22]]},"published-print":{"date-parts":[[2019,10]]}},"alternative-id":["10.1136\/bmjopen-2018-028525"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2018-028525","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2018-028525.supp1","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2018-028525.supp2","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.1136\/bmjopen-2018-028525.supp3","asserted-by":"subject"}]},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]}}}